Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

COVID-19 can cause various skin issues, from mild rashes to severe conditions.

Light-based therapy can help regrow hair in different types of hair loss, but more research is needed.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.

Mental health and hair loss are linked, and treating both can improve well-being.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

About 61% of women who had COVID-19 experienced hair loss afterward.

Anti-IL17A therapy reduced venous leg ulcer size by 64% without major side effects.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Melatonin, the sleep hormone, can help treat skin conditions like dermatitis, hyperpigmentation, and scalp disorders, and may also aid in skin aging prevention and regeneration. However, it's not recommended for asthma due to its pro-inflammatory effect.

Hair loss in Cronkhite-Canada syndrome may be due to an autoimmune response.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Many survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Togo suffer long-term eye and skin problems.

Higher testosterone and lower Vitamin D levels are linked to hair loss in female COVID-19 patients.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

Scalp seborrheic dermatitis is a common skin condition linked to oil production and bacteria, with specific diagnostic features and treatments like antifungals and corticosteroids.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

A neglected leprosy treatment led to rare scalp hair loss in an Indian woman, which improved with proper medication.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

A 16-year-old girl's skin rash was likely caused by an infection and improved with topical steroids.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.